Patrice A. Lee - Concepedia

Author

Patrice A. Lee

Array BioPharma (United States)ORCID

Also Known As

PATRICE A. LEE, Patrice A Lee, Patrice A. Lee

145

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Array BioPharma (United States)

About

Patrice A. Lee is an author at Array BioPharma (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	140
2	Biochemistry	2	2	46
3	Cell Biology	2	2	84
4	Natural Sciences	1	1	32
5	Biomolecular Engineering	1	1	32

Patrice A. Lee

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor Tammie C. Yeh, Vivienne Marsh, Bryan A. Bernat, Clinical Cancer Research	2007	575
Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock Patrick M. Honoré, J. Jamez, Michel Wauthier, Critical Care Medicine	2000	427
Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine Patrice A. Lee, James R. Matson, Robert W. Pryor, Critical Care Medicine	1993	123
Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine Patrice A. Lee, Gayle W. Weger, Robert W. Pryor, Critical Care Medicine	1998	92
Secretory Leukocyte Protease Inhibitor Prevents Allergen-Induced Pulmonary Responses in Animal Models of Asthma Clifford D. Wright, Andrew M. Havill, Scot Middleton, Journal of Pharmacology and Experimental Therapeutics	1999	52
Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in Mice Patrice A. Lee, Lawrence M. Blatt, Karin S. Blanchard, Hepatology	2000	49
Abstract 852: ARRY-380, a potent, small molecule inhibitor of ErbB2, increases survival in intracranial ErbB2+ xenograft models in mice Victoria Dinkel, Deborah Anderson, Shannon L. Winski, Cancer Research Small Molecule InhibitorPharmacotherapyExperimental PharmacologyMechanical InjectionsTumor Biology	2012	47
Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor Patrice A. Lee, Eli Wallace, Allison Marlow, Cancer Research ImmunologyPharmacotherapySelective Mek 1/2Cancer BiologyTumor Biology	2010	37
Identification of a New Class of Glucokinase Activators through Structure-Based Design Ronald J. Hinklin, Steven A. Boyd, Mark J. Chicarelli, Journal of Medicinal Chemistry Protein AssemblyGlycobiologyInsulin SignalingEnzyme Kinetic ParametersStructure-based Design	2013	32
Efficacy and Safety of ARRY-371797 in <i>LMNA</i> -Related Dilated Cardiomyopathy: A Phase 2 Study Calum A. MacRae, Matthew R.G. Taylor, Luisa Mestroni, Circulation Genomic and Precision Medicine	2022	17

Page 1